Literature DB >> 10700236

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

K Ohashi1, P L Marion, H Nakai, L Meuse, J M Cullen, B B Bordier, R Schwall, H B Greenberg, J S Glenn, M A Kay.   

Abstract

Persistence of hepatocytes transplanted into the same or related species has been established. The long-term engraftment of human hepatocytes into rodents would be useful for the study of human viral hepatitis, where it might allow the species, technical and size limitations of the current animal models to be overcome. Although transgenic mice expressing the hepatitis B virus (HBV) genome produce infectious virus in their serum, the viral life cycle is not complete, in that the early stages of viral binding and entry into hepatocytes and production of an episomal transcriptional DNA template do not occur. As for hepatitis delta virus (HDV), another cause of liver disease, no effective therapy exists to eradicate infection, and it remains resistant even to recent regimens that have considerably changed the treatment of HBV (ref. 13). Here, we demonstrate long-term engraftment of primary human hepatocytes transplanted in a matrix under the kidney capsule of mice with administration of an agonistic antibody against c-Met. These mice were susceptible to HBV infection and completion of the viral life cycle. In addition, we demonstrate super-infection of the HBV-infected mice with HDV. Our results describe a new xenotransplant model that allows study of multiple aspects of human hepatitis viral infections, and may enhance studies of human liver diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700236     DOI: 10.1038/73187

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  40 in total

1.  Transplantation of human cells in the peritoneal cavity of immunodeficient mice for rapid assays of hepatitis B virus replication.

Authors:  Mukesh Kumar; Sriram Bandi; Kang Cheng; Sanjeev Gupta
Journal:  Xenotransplantation       Date:  2011 Nov-Dec       Impact factor: 3.907

2.  Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Authors:  Yongjun Jiao; Ping Zhao; Jin Zhu; Tessa Grabinski; Zhengqing Feng; Xiaohong Guan; R Scot Skinner; Milton D Gross; Rick V Hay; Hiroshi Tachibana; Brian Cao
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

Review 3.  MET targeted therapy for lung cancer: clinical development and future directions.

Authors:  Yan Feng; Patrick C Ma
Journal:  Lung Cancer (Auckl)       Date:  2012-08-09

4.  Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.

Authors:  S Ren; M Nassal
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.

Authors:  J Chang; L J Sigal; A Lerro; J Taylor
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice.

Authors:  Martha J Harding; Christin M Lepus; Thomas F Gibson; Benjamin R Shepherd; Scott A Gerber; Morven Graham; Frank X Paturzo; Christoph Rahner; Joseph A Madri; Alfred L M Bothwell; Brett D Lindenbach; Jordan S Pober
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Inhibition of hepatitis B virus gene expression and replication by ribonuclease P.

Authors:  Chuan Xia; Yuan-Chuan Chen; Hao Gong; Wenbo Zeng; Gia-Phong Vu; Phong Trang; Sangwei Lu; Jianguo Wu; Fenyong Liu
Journal:  Mol Ther       Date:  2013-03-12       Impact factor: 11.454

9.  Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens.

Authors:  Nicolas Brezillon; Dina Kremsdorf; Mary C Weiss
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

10.  Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621.

Authors:  Neil R Michaud; Jitesh P Jani; Stephen Hillerman; Konstantinos E Tsaparikos; Elsa G Barbacci-Tobin; Elisabeth Knauth; Henry Putz; Mary Campbell; George A Karam; Boris Chrunyk; David F Gebhard; Larry L Green; Jinghai J Xu; Margaret C Dunn; Tim M Coskran; Jean-Martin Lapointe; Bruce D Cohen; Kevin G Coleman; Vahe Bedian; Patrick Vincent; Shama Kajiji; Stefan J Steyn; Gary V Borzillo; Gerrit Los
Journal:  MAbs       Date:  2012-09-24       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.